Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults

Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved GeodonĀ® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults…

read the full article

If you enjoyed this post, make sure you subscribe to my RSS feed!
This entry was posted in Bipolar Disorder and tagged Bipolar Disorder, disorder, psychology. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>